The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Diagnosing and Treating MPNs

Srdan Verstovsek, MD, PhD
Published Online: 4:43 PM, Thu September 8, 2016

Srdan Verstovsek, MD, PhD, Chief, Section for Myeloproliferative Neoplasms at the University of Texas MD Anderson Cancer Center, Department of Leukemia, discusses identifying and treating different myeloproliferative neoplasms (MPNs).

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.